Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MSH2 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of MSH2 mRNA | decreases expression | 18648102
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MSH2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MSH2 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MSH2 mRNA | decreases expression | 20064835
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in decreased expression of MSH2 mRNA | decreases expression | 17481689
|
D002104 |
Cadmium |
Cadmium results in decreased activity of MSH2 protein | decreases activity | 16677676
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA | affects cotreatment|decreases expression | 12634122
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA | affects cotreatment|decreases expression | 12634122
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of MSH2 mRNA | decreases expression | 11906922
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MSH2 mRNA | decreases expression | 20106945
|
C014347 |
decitabine |
decitabine results in decreased methylation of MSH2 promoter | decreases methylation | 19032668
|
C014347 |
decitabine |
decitabine results in increased expression of MSH2 mRNA | increases expression | 19032668
|
D016190 |
Carboplatin |
Carboplatin results in decreased expression of MSH2 mRNA | decreases expression | 18172885
|
D002945 |
Cisplatin |
MSH2 protein affects the susceptibility to Cisplatin | affects response to substance | 12185594
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of MSH2 mRNA | decreases expression | 18172885
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of MSH2 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of MSH2 protein | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MSH2 mRNA] | decreases reaction|increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MSH2 protein] | decreases reaction|increases expression | 17854601
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MSH2 mRNA | decreases expression | 12655037
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of MSH2 gene | increases mutagenesis | 16495775
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of MSH2 mRNA | decreases expression | 16709241 16557594
|
D005472 |
Fluorouracil |
MSH2 protein affects the susceptibility to Fluorouracil | affects response to substance | 18949393
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of MSH2 mRNA | increases expression | 16849584
|
C027185 |
indirubin |
indirubin results in decreased expression of MSH2 mRNA | decreases expression | 15056799
|
C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of MSH2 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in decreased expression of MSH2 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
MSH2 protein affects the susceptibility to irinotecan | affects response to substance | 18949393
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA | affects cotreatment|decreases expression | 12634122
|
D001556 |
Lindane |
Lindane results in decreased expression of MSH2 mRNA | decreases expression | 17785943
|
C015329 |
lycopene |
lycopene results in increased expression of MSH2 mRNA | increases expression | 16886892
|
D008466 |
Mechlorethamine |
MSH2 protein affects the susceptibility to Mechlorethamine | affects response to substance | 12185594
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of MSH2 mRNA | increases expression | 12634122
|
D008770 |
Methylnitrosourea |
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] | affects binding|increases reaction | 16204460
|
D008770 |
Methylnitrosourea |
Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] | affects binding|increases reaction | 16204460
|
D008770 |
Methylnitrosourea |
MSH2 protein affects the susceptibility to Methylnitrosourea | affects response to substance | 12185594
|
C020300 |
monomethylarsonic acid |
monomethylarsonic acid results in decreased expression of MSH2 mRNA | decreases expression | 17481689
|
D010126 |
Ozone |
Ozone results in increased expression of MSH2 mRNA | increases expression | 16716893
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MSH2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011743 |
Pyrimidines |
MSH2 protein results in increased susceptibility to Pyrimidines | increases response to substance | 15611052
|
D011743 |
Pyrimidines |
MSH2 protein results in increased susceptibility to Pyrimidines | increases response to substance | 15611052
|
D011794 |
Quercetin |
Quercetin results in increased expression of MSH2 mRNA | increases expression | 14715546
|
D011794 |
Quercetin |
Quercetin results in increased expression of MSH2 mRNA | increases expression | 18095365
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA | affects cotreatment|decreases expression | 12634122
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MSH2 mRNA | increases expression | 19465110
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of MSH2 mRNA | decreases expression | 17951470
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of MSH2 mRNA | decreases expression | 18230668
|
D014501 |
Uranium |
Uranium affects the expression of MSH2 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of MSH2 mRNA | affects expression | 15672453
|
C088658 |
zoledronic acid |
zoledronic acid results in decreased expression of MSH2 protein | decreases expression | 17070308
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.44 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.14 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.52 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.87 | 12690470 17670903 15814532 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
7.87 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.73 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.06 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.25 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
12.25 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.25 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
12.25 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
12.25 | 15113128 15688392 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
13.93 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
13.93 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
13.93 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
13.93 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.85 | 17162532 19061943 18056438 19052882 16434500 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.85 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.85 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.27 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.47 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
3.96 | 12661182 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.28 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.34 | 15513908 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.48 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.48 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.87 | 17084956 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.66 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
8.81 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.81 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.32 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.32 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.29 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.29 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
4.47 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.47 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.56 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.39 | 15687053 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.00 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.00 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.59 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.11 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.11 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.11 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.36 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.49 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.46 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.57 | 11697798 15867366 19442620 16121404 17312309 16778634 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.33 | 11869084 18404659 16769263 8053405 15845617 18496637 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.52 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
3.93 | 16357521 16436596 18412241 16651633 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
10.41 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
10.41 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
10.41 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
10.41 | 17388661 12006526 18234424 16978400 11325840 15136595 17020986 15093573 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
10.41 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
10.41 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
10.41 | 19217205 18608205 15136595 18357371 16110121 16557594 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
10.41 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
10.41 | 16253758 14633655 11306469 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
10.41 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
10.41 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
10.41 | 16166294 16873071 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
10.41 | 18695136 16096432 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.35 | 16777450 14754758 17626835 15516495 19059883 18417511 18315731 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.17 | 16813970 |
MESH:D002057 |
Burns, Chemical |
|
Mechlorethamine |
5.81 | 9625245 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.32 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.12 | 16962696 |
MESH:C537421 |
Cafe au lait spots, multiple |
marker/mechanism |
|
| |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.24 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.09 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.09 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.73 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
21.19 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
21.19 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
21.19 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
21.19 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
21.19 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
21.19 | 16540662 20432363 17138121 19519916 20727157 18056438 19383236 18978308 3084413 19394651 18494052 19335982 20101231 3581430 20214788 19418558 18393292 20524982 19107877 20084675 17978847 18785209 20512989 18691550 18788625 16681979 19539802 20007298 10672840 18665156 16878318 18506893 17173139 17428255 17055752 19701751 19052882 18971187 19208518 20935162 19919837 16807293 16288022 21159647 18210153 10737359 16502159 19822196 16569478 16779866 17761372 11831363 17162532 16698587 20514400 16830150 19171122 16328049 16935385 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
21.19 | 16332177 17088986 17971768 18930000 16799960 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
21.19 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
21.19 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
21.19 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.47 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Carboplatin |
8.34 | 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
8.34 | 12023789 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
8.34 | 19233551 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.55 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
13.71 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
13.71 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
13.71 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
13.71 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
16.27 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
16.27 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
16.27 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
16.27 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
16.27 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
16.27 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.00 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.00 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
6.90 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.90 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
32.26 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
32.26 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
32.26 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
32.26 | 17174075 7505956 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
32.26 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
32.26 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
32.26 | 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
32.26 | 19524636 20056578 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.56 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.17 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.15 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.15 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
16.66 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.66 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.66 | 16919318 17110522 16105132 11677210 15861022 17333356 17681005 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
16.66 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.73 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.14 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.14 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.30 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
7.57 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
7.57 | 17725105 16340194 16510598 18772588 15001691 17172411 17287894 17018589 17016597 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
7.57 | 17725105 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
7.57 | 11134977 17148506 19056647 16640504 19440933 15741050 17191121 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 18949393 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
5.96 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
5.96 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
5.96 | 20501625 18448328 16303861 16391804 18383874 18949393 17454858 18288408 16282729 17094418 16331619 15148649 16524972 14970324 17401013 17594712 18802399 17255274 18509181 17016601 17695437 15289873 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
5.96 | 18259882 17454858 17159606 15273666 16391804 16303861 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
5.96 | 18095365 18852136 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.71 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
3.63 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.63 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.63 | 9125849 9664655 9211117 16925845 9142499 14991402 8800419 10589399 9224671 17551590 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.61 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.56 | 15276878 17010015 12388444 12161096 18372110 18295254 10498854 18710439 15643279 11948286 18433785 18093676 12913760 10700343 16614059 18483878 16413132 16651033 17979934 16989017 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.37 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.42 | 12868966 11298694 8156756 14531868 18759878 8970840 2524372 11906362 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.22 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.11 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
7.54 | 10990075 11751995 15331540 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
7.54 | 19496084 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.08 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.83 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.83 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
7.80 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
7.80 | 9653073 18289764 7440962 1440618 11289319 18692083 18648102 6482804 9328219 9022650 16192314 8291058 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
7.80 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
7.80 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.14 | 15033597 12231392 19839026 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.14 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.56 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.32 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.32 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.52 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.52 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.79 | 12538720 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.69 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
2.83 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.66 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.81 | 11006010 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.69 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.38 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.38 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
9.38 | 17638652 15173087 16785472 16481741 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
9.38 | 16337965 17638652 15173087 16785472 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.80 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.80 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.67 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
15.67 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.67 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.67 | 20131406 19236843 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.41 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.05 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
4.98 | 19769572 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.59 | 6705139 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
4.81 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
17.80 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
17.80 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
17.80 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
17.80 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.26 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.80 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
10.40 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
10.40 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
10.40 | 17312396 |
MESH:D005910 |
Glioma |
marker/mechanism |
|
| |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
12.72 | 18412241 16651633 16357521 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
12.72 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
12.72 | 9825942 |
MESH:D005910 |
Glioma |
|
Quercetin |
12.72 | 17643826 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.09 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.65 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.17 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.63 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
16.12 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
16.12 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
16.12 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
16.12 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.94 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.73 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.08 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.75 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.75 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.75 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.28 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.00 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.88 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.96 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.11 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.12 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.91 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.91 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
10.37 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
10.37 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
10.37 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.62 | 18606429 8697196 16959395 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.10 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
7.10 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.67 | 19622757 18089816 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.16 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
8.04 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
8.04 | 11834736 18262572 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.53 | 15034207 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
5.51 | 11275354 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.57 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
7.57 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.57 | 18850075 18670907 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.77 | 12669777 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.40 | 16569931 16945680 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.90 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.08 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
18.13 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
18.13 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
18.13 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
18.13 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
18.13 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
4.15 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.15 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.08 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.36 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.36 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.59 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.69 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.69 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.55 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.01 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.71 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
20.64 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
20.64 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
20.64 | 12649298 18289764 19839026 15190930 12231392 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
20.64 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
20.64 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
20.64 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
19.75 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
19.75 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
19.75 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
19.75 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
19.75 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.37 | 11231351 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
13.21 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
13.21 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Quercetin |
13.21 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
13.21 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.31 | 17802794 17296974 18172266 17658394 17008537 18587576 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.39 | 18089816 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.78 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
8.32 | 19117987 17236224 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.32 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.67 | 18460780 19010910 17679729 18704418 19387464 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.67 | 17596541 16294345 19850784 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.03 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.88 | 17712046 19029980 19075265 16766008 9834237 16331271 17339181 15748426 17361223 17649720 17107899 17301526 17368321 19225113 16788101 17217047 16891316 16140955 19642359 12679006 19035177 17506722 16823087 16935935 17294898 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.55 | 10052129 11830472 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
7.46 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.46 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.59 | 18522880 19638242 18407596 18665156 20032147 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.93 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.45 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
4.45 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.45 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.45 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.04 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
4.04 | 1715830 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
22.89 | 15890375 9163691 18177683 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.89 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
22.89 | 20101389 10737359 20137499 20492335 12112319 21071580 19294768 20405173 19254457 2862719 18977376 21167192 19690152 16942905 18648771 21047994 20452335 2422723 19850985 19551842 20434301 19642983 18754104 20501860 19812893 19499222 18644402 19833225 15175105 9163691 15885732 19426721 19638242 20118626 12771043 19256749 19255062 18978307 19996281 19073162 20583210 19427195 19090486 21278145 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
22.89 | 16603448 18383874 17045692 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.89 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
22.89 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
22.89 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.89 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
15.81 | 598648 1399818 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
15.81 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
15.81 | 18093689 19539802 9362446 19009564 19126423 18775883 16842330 17854601 17942915 21159647 2563599 16267830 19004024 18079962 18308698 18544905 19519916 18282651 18253720 3124819 17174075 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
15.81 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.81 | 12151625 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.05 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.57 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.57 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.44 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
19.05 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
19.05 | 20869020 18816296 6695378 20464547 18520028 18569708 20135361 20064080 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
19.05 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
19.05 | 6695378 20970405 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
19.05 | 17703301 16019985 6695378 16271038 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
19.05 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
19.05 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
19.05 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
19.05 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
19.05 | 19931552 16712894 17306315 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
19.05 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.37 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
15.51 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
15.51 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
15.51 | 15790496 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
15.51 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
9.36 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
9.36 | 14633661 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
3.83 | 11911406 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.64 | 15375218 |
MESH:C537261 |
Lynch syndrome I (site-specific colonic cancer) |
marker/mechanism |
|
| |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
8.76 | 10767621 18041768 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
8.76 | 11751437 15688392 14999141 16051031 16619500 10838139 15113128 17131329 15313902 17020996 11807958 12931682 14633655 16827153 16944150 10767621 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
8.76 | 17312309 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.61 | 17453147 |
MESH:D008545 |
Melanoma |
|
Carboplatin |
8.87 | 11712820 12040289 16225601 16342250 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
8.87 | 17761969 15577323 18505091 18332650 16248763 12393984 16432458 18176117 17023156 11135225 16809738 12374674 12883367 |
MESH:D008545 |
Melanoma |
|
decitabine |
8.87 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.87 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.87 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.36 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.39 | 16388313 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.56 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.02 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.11 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
6.11 | 16675582 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.36 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.68 | 10496685 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.47 | 17671175 |
OMIM:276300 |
MISMATCH REPAIR CANCER SYNDROME |
marker/mechanism |
|
| |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.46 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.46 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.59 | 17159606 |
MESH:D055653 |
Muir-Torre Syndrome |
marker/mechanism |
|
| |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
6.74 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
6.74 | 16996129 18089719 19621390 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.10 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
6.66 | 19157545 19010910 18608210 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.66 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.10 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.10 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.69 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.37 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
7.37 | 19207477 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.44 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
12.15 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
12.15 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
12.15 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
12.15 | 17312309 19139120 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
46.00 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Carboplatin |
46.00 | 18854779 17925555 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
46.00 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
46.00 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
46.00 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
46.00 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
Lindane |
46.00 | 12807735 16818664 |
MESH:D009369 |
Neoplasms |
|
lycopene |
46.00 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
46.00 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
46.00 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
46.00 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
46.00 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
46.00 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
13.10 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
13.10 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
13.10 | 20056578 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.07 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.01 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.93 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.19 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.19 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
10.52 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.52 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.52 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
11.89 | 16651423 16003739 17160924 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
11.89 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
10.27 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
10.27 | 8761367 16115947 15176712 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
10.27 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.00 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Carboplatin |
23.81 | 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
23.81 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
23.81 | 8761367 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
23.81 | 8761367 |
MESH:D009456 |
Neurofibromatosis 1 |
marker/mechanism |
|
| |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
3.98 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.69 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.15 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.94 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.70 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.68 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
7.68 | 4026338 6482804 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.56 | 17160924 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.29 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.59 | 3988306 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
4.95 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
3.77 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
3.83 | 19495926 |
MESH:D010051 |
Ovarian Neoplasms |
marker/mechanism |
|
| 19032668 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
13.42 | 19769630 15464296 6897625 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
13.42 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
13.42 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.42 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.42 | 16936753 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
9.55 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Tretinoin |
9.55 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
9.55 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
26.48 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
26.48 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
26.48 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
26.48 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
26.48 | 15113037 16929163 16500647 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
26.48 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
26.48 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
26.48 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.30 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.08 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.82 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.91 | 15464296 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
4.96 | 15687053 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.72 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.04 | 6228378 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.92 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.98 | 18929643 18381685 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.16 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
13.29 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
13.29 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
13.29 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.56 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.78 | 11118676 11222880 11896295 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.32 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.33 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
3.33 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.33 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.33 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
3.33 | 14688026 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
3.33 | 15084515 17337101 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
3.33 | 12376480 15682402 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
3.33 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.33 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
3.33 | 19103299 12438248 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.22 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.90 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.07 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.37 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.11 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.66 | 18722050 15538739 18286688 16160472 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.00 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.17 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.07 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
8.07 | 18172121 18155124 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.07 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.66 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.66 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
9.38 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
9.38 | 16121404 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.12 | 16862918 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.44 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.32 | 18551238 |
MESH:D012640 |
Seizures |
|
Lindane |
5.32 | 15475178 12842176 7539098 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonic acid |
3.89 | 21378128 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
11.82 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
11.82 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
11.82 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
11.82 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.92 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.52 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.09 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.47 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
11.70 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
11.70 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
11.70 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
11.70 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
11.70 | 17172411 16951190 17498489 18396642 16424979 17522103 18567086 15786421 19084572 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
11.70 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
11.70 | 15930296 16257854 18593901 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
11.70 | 17261132 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Carboplatin |
11.08 | 12837982 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
11.08 | 12837982 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.24 | 17225452 15464296 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.23 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.80 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
10.90 | 15790496 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
10.90 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.47 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
19.11 | 1399818 6582329 7505956 3712494 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
19.11 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
19.11 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
19.11 | 7505956 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
19.11 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.62 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.62 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.96 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
29.54 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
29.54 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
29.54 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
29.54 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
29.54 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
29.54 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
29.54 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
29.54 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
29.54 | 11723127 17306315 16452187 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.90 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
19.66 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
19.66 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
19.66 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
19.66 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.90 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.40 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.40 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.56 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.20 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.01 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.17 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.16 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.66 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.29 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.82 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.61 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.01 | 17120751 |